Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems

International Journal of Pharmaceutics

Volumn 374, Issue 1-2, 2009, Pages 66-72

  Balakrishnan, Prabagar ^a   Lee, Beom Jin ^b   Oh, Dong Hoon ^a   Kim, Jong Oh ^a   Lee, Young Im ^a   Kim, Dae Duk ^c   Jee, Jun Pil ^c   Lee, Yong Bok ^d   Woo, Jong Soo ^a   Yong, Chul Soon ^a   Choi, Han Gon ^a  

^a Yeungnam University   (South Korea)

^b Kangwon National University   (South Korea)

^c Seoul National University   (South Korea)

^d Chonnam National University   (South Korea)

Author keywords

Bioavailability; Coenzyme Q10; Self emulsifying drug delivery system; Solubility

Indexed keywords

COSURFACTANT; LABRASOL; OIL; UBIDECARENONE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; EMULSION; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; ZETA POTENTIAL;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; DRUG DELIVERY SYSTEMS; EMULSIONS; GLYCERIDES; MALE; OILS; ORGANIC CHEMICALS; PARTICLE SIZE; PHASE TRANSITION; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; SURFACE-ACTIVE AGENTS; UBIQUINONE; VITAMINS;

EID: 67349166936     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.03.008     Document Type: Article

References (40)

1. Aberg F., Appelkvist E.L., Dallner G., and Ernster L. Distribution and redox state of ubiquinone in rat and human tissues. Arch. Biochem. Biophys. 295 (1992) 230-234
2. Bachynsky M.O., Shah N.H., Patel C.I., and Malick A.W. Factors affecting the efficiency of self-emulsifying oral delivery system. Drug Dev. Ind. Pharm. 23 (1997) 809-816
3. Belardinelli R., Mucaj A., Lacalaprice F., Solenghi M., Seddaiu G., Principi F., Tiano L., and Littarru G.P. Coenzyme Q10 and exercise training in chronic heart failure. Eur. Heart J. 27 (2006) 2675-2681
4. Bentinger M., Dallner G., Chojnacki T., and Swiezewska E. Distribution and breakdown of labeled Coenzyme Q10 in rat. Free Radic. Biol. Med. 34 (2003) 563-575
5. Bhagavan H.N., and Chopra R.K. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Mitochondrion 7 (2007) S78-S88
6. Bhandari K.H., Newa M., Kim J.A., Yoo B.K., Woo J.S., Lyoo W.S., Lim H.T., Choi H.J., and Yong C.S. Preparation, characterization and evaluation of coenzyme Q10 binary solid dispersions for enhanced solubility and dissolution. Biol. Pharm. Bull. 30 (2007) 1171-1176
7. Caliph S.M., Charman W.N., and Porter C.J.H. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J. Pharm. Sci. 89 (2000) 1073-1084
8. Chen Y., Li G., Wu X., Chen Z., Hang J., Qin B., Chen S., and Wang R. Self-microemulsifying drug delivery system (SMEDDS) of vinpocetine: formulation development and in vivo assessment. Biol. Pharm. Bull. 1 (2008) 118-215
9. Chi S.C. Enhanced dissolution rate of biphenyl dimethyl dicarboxylate using SMEDDS. Bull. Tech. Gattefosse 92 (1999) 75-80
10. Chopra R.K., Goldman R., Sinatra S.T., and Bhagavan H.N. Relative bioavailability of coenzyme Q10 formulations in human subjects. Int. J. Vitam. Nutr. Res. 68 (1998) 109-113
11. Constanitinides P.P., Scalart J.P., Lancaster C., Marcello J., Marks G., and Ellens H. Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides. Pharm. Res. 11 (1994) 1385-1390
12. Craig D.Q.M., Barker S.A., Banning D., and Booth S.W. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int. J. Pharm. 114 (1995) 103-110
13. Eaimtrakarn S., Prasad R.Y.V., Ohno T., Konishi T., Yoshikawa Y., Shibata N., and Takada K. Absorption enhancing effect of labrasol on the intestinal absorption of insulin in rats. J. Drug Target. 10 (2002) 255-326
14. Gershanik T., Benzeno S., and Benita S. Interaction of the self-emulsifying lipid drug delivery system with mucosa of everted rat intestine as a function of surface charge and droplet size. Pharm. Res. 15 (1998) 863-869
15. Jackson M.J. Drug transport across gastrointestinal epithelial. Physiology of the Gastrointestinal Tract (1987), Raven Press, New York pp. 1597-1621
16. Joo, S.J., 2005. Coenzyme Q10 and Cardiovascular Health: To Take or Not to Take-That is the Question. Nutrition Bytes 10, Article 4.
17. Kang B.K., Lee J.S., Chon S.K., Jeong S.Y., Yuk S.H., Khang G., Lee H.B., and Cho S.H. Development of selfmicroemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int. J. Pharm. 274 (2004) 65-73
18. Kimura A., Yamaguchi H., Watanabe K., Hayashi M., and Awazu S. Factors influencing the tissue distribution of Coenzyme Q10 intraveneously administered in an emulsion to rats: emulsifying agents and lipoprotein lipase activity. J. Pharmacol. 38 (1986) 659-662
19. Koga K., Kusawake Y., Ito Y., Sugioka N., Shibata N., and Takada K. Enhancing mechanism of Labrasol on intestinal membrane permeability of the hydrophilic drug gentamicin sulfate. Eur. J. Pharm. Biopharm. 64 (2006) 82-91
20. Kommuru T.R., Gurley B., Khan M.A., and Reddy I.K. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int. J. Pharm. 212 (2001) 233-246
21. Kovacs, I., Jusztin, M., Takacs, E., Balazs, Z., Kiss, I., Varga, Z., Jancso, S., Heim, C., Korcsmavos, I.K., Erdohati, E., Jarabin, M., 1996. US Patent, No. 5 583 105.
22. Langsjoen P.H., and Langsjoen A.M. Coenzyme Q10 in cardiovascular disease with special emphasis on heart failure and myocardial, ischemia. Asia Pac. Heart J. 7 (1998) 160-168
23. Lindmark T., Nikkila T., and Artursson P. Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 monolayers. J. Pharmacol. Exp. Ther. 275 (1995) 958-964
24. Lutka A., and Pawlaczyk J. Inclusion complexation of coenzyme Q10 with cyclodextrins. Acta Pol. Pharm. 52 (1995) 379-386
25. Miles M.V. The uptake and distribution of coenzyme Q(10). Mitochondrion 7S (2007) S72-S77
26. Nazzal S., Smalyukh I.I., Lavrentovich O.D., and Mansoor A.K. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int. J. Pharm. 235 (2002) 247-265
27. New, R.R.C., Kirby, C.J., 1999. Solubilisation aids. US Patent 5968549.
28. Omotosho J.A., Whateley T.L., Law T., and Florence A.T. The nature of the oil phase and the release of solutes from multiple w/o/w emulsions. J. Pharm. Pharmacol. 38 (1986) 865-870
29. Ozawa Y., Mizushima Y., and Koyama I. Intestinal absorption of Coenzyme Q10 with lipid microsphere. Drug Res. 36 (1986) 689-690
30. Porter C.J.H., and Charman W.N. Uptake of drugs into the intestinal lymphatics after oral administration. Adv. Drug Deliv. Rev. 25 (1997) 71-89
31. Pouton C.W. Effects of inclusion of a model drug on the performance of selfemulsifying formulations. J. Pharm. Pharmacol. 37 (1985) 1-11
32. Pouton C.W. Formulation of self-emulsifying drug delivery systems. Adv. Drug Deliv. Rev. 25 (1997) 47-58
33. Prasad R.Y.V., Puthli S.P., Eaimtrakarn S., Ishida M., Yoshikawa Y., Shibata N., and Takada K. Enhanced intestinal absorption of vancomycin with Labrasol and D-α-tocopheryl PEG 1000 succinate in rats. Int. J. Pharm. 250 (2003) 181-190
34. Shah N.H., Carvajal M.T., Patel C.I., Infeld M.H., and Malick A.W. Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int. J. Pharm. 106 (1994) 15-23
35. Society of Toxicology (SOT), 1999. Guiding Principles in the Use of Animals in Toxicology, www.toxicology.org/AI/FA/guidingprinciples.pdf.
36. Swenson E.S., and Curatolo W.J. Means to enhance penetration. Adv. Drug. Del. Rev. 8 (1992) 39-42
37. Takada M., Yuzuriha T., Katayama K., Yamato C., and Koyama N. Targeting of Coenzyme Q10 solubilized with soy lecithin to heart of guinea pigs. J. Nutr. Sci. Vitaminol. 31 (1985) 115-120
38. Takeuchi H., Sasaki H., Niwa T., Hino T., Kawashima Y., Uesugi K., and Ozawa H. Improvement of photostability of ubidecarenone in the formulation of novel powdered dosage forms termed redispersable dry emulsion. Int. J. Pharm. 86 (1992) 25-33
39. Wilson C.G., and Mahony B.O. The behavior of fats and oils in the upper G. I. tract. Bull. Tech. Gattefosse 90 (1997) 13-18
40. Woo J.S., Kim T.S., Park J.H., and Chi S.C. Formulation and biopharmaceutical evaluation of silymarin using SMEDDS. Arch. Pharm. Res. 30 (2007) 82-89